2019 ICD-10-CM Diagnosis Code B16

Acute hepatitis B

    2016 2017 2018 2019 Non-Billable/Non-Specific Code
  • B16 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
  • The 2019 edition of ICD-10-CM B16 became effective on October 1, 2018.
  • This is the American ICD-10-CM version of B16 - other international versions of ICD-10 B16 may differ.
The following code(s) above B16 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to B16:
  • A00-B99
    2019 ICD-10-CM Range A00-B99

    Certain infectious and parasitic diseases

    Includes
    • diseases generally recognized as communicable or transmissible
    Type 1 Excludes
    • certain localized infections - see body system-related chapters
    Type 2 Excludes
    • carrier or suspected carrier of infectious disease (Z22.-)
    • infectious and parasitic diseases complicating pregnancy, childbirth and the puerperium (O98.-)
    • infectious and parasitic diseases specific to the perinatal period (P35-P39)
    • influenza and other acute respiratory infections (J00-J22)
    Use Additional
    • code to identify resistance to antimicrobial drugs (Z16.-)
    Certain infectious and parasitic diseases
  • B15-B19
    2019 ICD-10-CM Range B15-B19

    Viral hepatitis

    Type 1 Excludes
    • sequelae of viral hepatitis (B94.2)
    Type 2 Excludes
    • cytomegaloviral hepatitis (B25.1)
    • herpesviral [herpes simplex] hepatitis (B00.81)
    Viral hepatitis
Code History
  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
Code annotations containing back-references to B16:
  • Use Additional: C22
    ICD-10-CM Diagnosis Code C22

    Malignant neoplasm of liver and intrahepatic bile ducts

      2016 2017 2018 2019 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • malignant neoplasm of biliary tract NOS (C24.9)
    • secondary malignant neoplasm of liver and intrahepatic bile duct (C78.7)
    Use Additional
ICD-10-CM Codes Adjacent To B16
B10.0 Other human herpesvirus encephalitis
B10.01 Human herpesvirus 6 encephalitis
B10.09 Other human herpesvirus encephalitis
B10.8 Other human herpesvirus infection
B10.81 Human herpesvirus 6 infection
B10.82 Human herpesvirus 7 infection
B10.89 Other human herpesvirus infection
B15 Acute hepatitis A
B15.0 Hepatitis A with hepatic coma
B15.9 Hepatitis A without hepatic coma
B16 Acute hepatitis B
B16.0 Acute hepatitis B with delta-agent with hepatic coma
B16.1 Acute hepatitis B with delta-agent without hepatic coma
B16.2 Acute hepatitis B without delta-agent with hepatic coma
B16.9 Acute hepatitis B without delta-agent and without hepatic coma
B17 Other acute viral hepatitis
B17.0 Acute delta-(super) infection of hepatitis B carrier
B17.1 Acute hepatitis C
B17.10 …… without hepatic coma
B17.11 …… with hepatic coma
B17.2 Acute hepatitis E

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.